SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-16-716891
Filing Date
2016-09-22
Accepted
2016-09-22 14:21:55
Documents
2
Group Members
COLUMN GROUP GP, LPCOLUMN GROUP II GP, LPCOLUMN GROUP II, LPDAVID V. GOEDDELPETER SVENNILSON

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d437010dsc13da.htm SC 13D/A 116251
2 EX-99.A d437010dex99a.htm EX-99.A 8730
  Complete submission text file 0001193125-16-716891.txt   126705
Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158 415-865-2050
COLUMN GROUP L P (Filed by) CIK: 0001347769 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Subject) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88256 | Film No.: 161897420
SIC: 2834 Pharmaceutical Preparations